| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |